Status:
COMPLETED
Intralesional Vitamin D Injection for Treatment of Common Warts
Lead Sponsor:
Stephen P. Merry
Conditions:
Warts
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Researchers are trying to find out if injecting Vitamin D into a wart is an effective treatment.
Eligibility Criteria
Inclusion
- Adult patients seen at the Mayo Clinic Rochester practices
- Patients suffering from one or more cutaneous warts as diagnosed by the examining physician at baseline visit on typical diagnostic characteristics
- Able to provide consent
- Both recalcitrant and non-recalcitrant warts will be included
Exclusion
- Patients with prior use of home or office-based destructive treatments for this wart(s) in the last 1 month with salicylic acid (SA) or cryotherapy
- Immunoadjuvant therapy for warts in the last 4 months (e.g Candida)
- History of vitamin D injection of warts ever
- High-dose vitamin D supplementation (\>4,000 IU daily or equivalent) in the preceding 3 months
- Pregnancy or lactation
- Facial or genital warts
- Lesions not felt by the examining clinician to be a wart (e.g., corns or calluses)
- Immunosuppression (to include immunosuppressive medications or conditions as judged by the physician evaluating the patient at the baseline visit).
- Allergy to sesame oil
Key Trial Info
Start Date :
October 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2023
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT04278573
Start Date
October 20 2020
End Date
April 4 2023
Last Update
April 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905